Search results

The development of pharmaceutical products, in dosage forms that the human body can safely and effectively metabolize, is a challenging undertaking. In this month's blog, we offer insight on the process, and a related podcast featuring our CDMO experts.

As the COVID-19 pandemic evolves across the globe, the search for effective therapies also continues to gain momentum, including the possibility of repurposing existing medications that may show effectiveness against COVID-19 symptoms.

Get to know David Grégoire, Vice President of Compliance and Regulatory Affairs at Altasciences.